(NYSE: ATR) Aptargroup's forecast annual revenue growth rate of 4.33% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 8.63%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.45%.
Aptargroup's revenue in 2026 is $3,933,243,000.On average, 10 Wall Street analysts forecast ATR's revenue for 2026 to be $255,278,232,935, with the lowest ATR revenue forecast at $246,631,199,391, and the highest ATR revenue forecast at $266,404,930,510. On average, 10 Wall Street analysts forecast ATR's revenue for 2027 to be $267,422,228,574, with the lowest ATR revenue forecast at $252,671,406,646, and the highest ATR revenue forecast at $282,236,631,631.
In 2028, ATR is forecast to generate $286,178,661,629 in revenue, with the lowest revenue forecast at $273,208,111,313 and the highest revenue forecast at $302,455,430,653.